| DMF號(hào):19011 | 項(xiàng)目狀態(tài):I | 項(xiàng)目類型:II | 提交日期:2005-12-07 | | 項(xiàng)目名稱:Cefditoren Pivoxil Drug Substance As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):19010 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2005-12-07 | | 項(xiàng)目名稱:Repaglinide Usp As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):18934 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2005-11-04 | | 項(xiàng)目名稱:Tiagabine Hydrochloride Usp As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):18906 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2005-10-24 | | 項(xiàng)目名稱:Sertraline Hydrochloride Drug Subtance As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):18559 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2005-08-03 | | 項(xiàng)目名稱:Esomeprazole Magnesium (Amorphous, Non-Sterile Bulk Drug Substance) As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):18114 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2005-02-22 | | 項(xiàng)目名稱:Galantamine Hydrobromide As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):18042 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2005-01-31 | | 項(xiàng)目名稱:Ziprasidone Hydrochloride As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):17897 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2004-12-15 | | 項(xiàng)目名稱:Valsartan As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):17796 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2004-10-29 | | 項(xiàng)目名稱:Irbesartan Usp As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):17484 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2004-06-21 | | 項(xiàng)目名稱:Atorvastatin Magnesium As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):17334 | 項(xiàng)目狀態(tài):I | 項(xiàng)目類型:II | 提交日期:2004-04-28 | | 項(xiàng)目名稱:Citalopram Hydrobromide As Manufactured In Madhya Pradesh, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):17026 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2003-12-15 | | 項(xiàng)目名稱:Tolterodine Tartrate As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):16980 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2003-11-25 | | 項(xiàng)目名稱:Clorazepate Usp As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):16973 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2003-11-21 | | 項(xiàng)目名稱:Cefprozil Usp (Non-Sterile Bulk) As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
| DMF號(hào):16968 | 項(xiàng)目狀態(tài):A | 項(xiàng)目類型:II | 提交日期:2003-11-19 | | 項(xiàng)目名稱:7-Amino-3-[(Z)-Propen-1-Yl]-3-Cephem-4-Carboxylic Acid (7-Apca) As Manufactured In Punjab, India. | | 項(xiàng)目持有人: Ranbaxy Laboratories Ltd | |
共有 104條記錄, 7頁,顯示 46-60 <<上一頁 1 2 3 4 5 6 7 下一頁>>
|